alexa Nebulized Epinephrine Treatment in Pediatric Emergency
ISSN: 2161-0665

Pediatrics & Therapeutics
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Short Communication

Nebulized Epinephrine Treatment in Pediatric Emergency Department

Halise Akca*, Nilden Tuygun and Can Demir Karacan

Department of Pediatric Emergency Medicine, Dr. Sami Ulus Maternity Children’s Health and Diseases Training and Research Hospital, Turkey

*Corresponding Author:
Halise Akca
Department of Pediatric Emergency Medicine
Dr. Sami Ulus Children’s Health and
Diseases Training and Research Hospital
Babur St., No: 44, Altindag, Ankara, Turkey
Tel: +90 312 3056048
E-mail: [email protected]

Received Date: April 26, 2014; Accepted Date: July 28, 2014; Published Date: July 30, 2014

Citation: Akca H, Tuygun N, Karacan CD (2014) Nebulized Epinephrine Treatment in Pediatric Emergency Department. Pediat Therapeut 4:210. doi:10.4172/2161-0665.1000210

Copyright: © 2014 Akca H, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

 

Abstract

Epinephrine, first isolated around 1900, is the main sympathomimetic agent released by the adrenal gland. It plays an integral role in the treatment of several diseases in the emergency department. It effects on alpha and beta adrenergic receptors. In lower doses, it usually causes systemic and pulmonary vasodilatation, with some increase in heart rate and stroke volume. A high dose causes intense systemic vasoconstriction. Its metabolism is rapid and half-life is less than 5 minutes.

 

Keywords

Share This Page

Additional Info

Loading
Loading Please wait..
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords